The follow-up results with sustained virologic response in chronic hepatitis C patients in anl urfa/Turkey

Objectives: The aim of the study was to evaluate sustained virological response (SVR) after treatment and factors thatinfluence SVR among patients treated for chronic hepatitis C (CHC).Materials and methods: The study was conducted in patients with CHC between April 2007 and March 2011, who hadachieved SVR following treatment. They were treated with PEG IFN-α and ribavirin. Patients, whose end of treatmentresponses were obtained without a SVR, received a second course of treatment.Results: A total of 124 patients, 61 female (49.2%) were enrolled in the study. The distribution of genotypes was: 102patients with genotype 1 (82.3%) and 22 with genotype 2 (17.7%). SVR was achieved in 78 patients (62.9%) (67 duringthe first course and 11 in the second) were followed up for a mean duration of 18.4±8.5 months. Positive predictive factorson SVR were female gender (P=0.01), low initial viral load (P=0.01), early virological response (EVR) development(P<0.001) and infection with genotype 2 (P<0.001).Conclusions: In conclusion, there was no recurrence of HCV infection beyond follow-up of 24 months in any of thepatients who obtained SVR. Female gender, low initial viral load, development of EVR and infection with genotype 2 wasdetermined to have a positive impact on SVR. J Microbiol Infect Dis 2012; 2(1): 14-20